Glencore’s (GLEN) “Sell” Rating Reaffirmed at Liberum Capital
Liberum Capital reissued their sell rating on shares of Glencore (LON:GLEN) in a report issued on Tuesday morning. Liberum Capital currently has a GBX 300 ($4.04) target price on the natural resources company’s stock.
Other equities research analysts have also recently issued research reports about the company. set a GBX 390 ($5.25) price target on Glencore and gave the company a buy rating in a report on Thursday, August 31st. Jefferies Group increased their price target on Glencore from GBX 400 ($5.38) to GBX 450 ($6.06) and gave the company a buy rating in a report on Thursday, August 31st. UBS set a GBX 350 ($4.71) price target on Glencore and gave the company a buy rating in a report on Wednesday, August 30th. BNP Paribas set a GBX 440 ($5.92) price target on Glencore and gave the company a buy rating in a report on Wednesday, September 6th. Finally, Citigroup reaffirmed a buy rating on shares of Glencore in a report on Wednesday, August 23rd. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the stock. Glencore presently has a consensus rating of Buy and a consensus target price of GBX 396.43 ($5.34).
Shares of Glencore (LON:GLEN) opened at GBX 362.75 ($4.88) on Tuesday. Glencore has a fifty-two week low of GBX 260.50 ($3.51) and a fifty-two week high of GBX 388.25 ($5.23).
Glencore Company Profile
Glencore plc is an integrated producer and marketer of commodities, such as metals and minerals, energy products, agricultural products and Corporate and other. The Metals and minerals segment is engaged in copper, zinc/lead, nickel, ferroalloys, alumina/aluminum and iron ore production and marketing.
Receive News & Ratings for Glencore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glencore and related companies with MarketBeat.com's FREE daily email newsletter.